Accent Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
CIP
Accent Capital Management's RGEN Position: Q3 2025 in Review
Accent Capital Management sold out of Repligen (RGEN) in Q3 2025, closing a stake of 29 shares — an estimated $3.61K sold.
Accent Capital Management first reported a position in RGEN in Q1 2025 and held it in 2 quarters. The position peaked at $3.69K in Q1 2025. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.
- Accent Capital Management reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
- Accent Capital Management sold 29 Repligen shares in Q3 2025, an estimated $3.61K.
- Accent Capital Management first reported a position in Repligen in Q1 2025 and held it in 2 quarters.
- Accent Capital Management's Repligen position peaked at $3.69K in Q1 2025.
- 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.
Based on Accent Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.